# Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core

> **NIH NIH N01** · DUKE UNIVERSITY · 2024 · $2,501,263

## Abstract

To design, implement and manage ethical and statistically sound clinical trials and human challenge studies for influenza vaccines, vaccine components and delivery systems developed by the NIAID Collaborative Influenza Vaccine Innovation Centers. Current efforts include a Phase I clinical trial.

## Key facts

- **NIH application ID:** 11041317
- **Project number:** 75N93019C00054-P00015-9999-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** CHIP WALTER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,501,263
- **Award type:** —
- **Project period:** 2019-09-16 → 2026-09-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11041317

## Citation

> US National Institutes of Health, RePORTER application 11041317, Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core (75N93019C00054-P00015-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11041317. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*